Potential Clinical Applications of 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Mammography in Breast Cancer
IH Cho, EJ Kong - Nuclear Medicine and Molecular Imaging, 2017 - Springer
The whole-body positron emission tomography (PET)/magnetic resonance (MR) scan is a
cutting edge technology providing comprehensive structural information from MR imaging …
cutting edge technology providing comprehensive structural information from MR imaging …
PET/MRI in breast cancer
WV Vogel, U Nestle, MC Valli - Clinical and Translational Imaging, 2017 - Springer
This review aims to evaluate the respective values of MRI and FDG PET and their
combination as a single imaging device in detection, staging, treatment selection, response …
combination as a single imaging device in detection, staging, treatment selection, response …
Role of PET/CT in Radiotherapy Treatment Planning
This chapter focuses on the rationale, target validation, dose prescription verification and
evaluation, and recent clinical achievements in the field of integrating positron emission …
evaluation, and recent clinical achievements in the field of integrating positron emission …
[PDF][PDF] The 18F-fluorodeoxyglucose positron emission tomography/computed tomography in breast cancer
J Mihailović, M Ubavić - Vojnosanitetski pregled, 2017 - doiserbia.nb.rs
Oncology Institute of Vojvodina,* Department of Nuclear Medicine, Sremska Kamenica,
Serbia; University of Novi Sad,† Technical Faculty “Mihajlo Pupin”, Zrenjanin, Serbia;‡ …
Serbia; University of Novi Sad,† Technical Faculty “Mihajlo Pupin”, Zrenjanin, Serbia;‡ …
[PDF][PDF] Breast Cancer: Comparison Study between Early Stage and Locally Advanced Disease
Aim: Initial staging in breast cancer is considered as locoregional and systemic disease.
Distant metastases is rarely expected in early stage breast cancer patients. Although, we …
Distant metastases is rarely expected in early stage breast cancer patients. Although, we …
[HTML][HTML] Evaluation of internal mammary lymph nodes with MRI in breast cancer patients
UA Ozcan, T Aksoy, E Yildiz, E Tezcanlı, S Ulus… - 2017 - epos.myesr.org
Aims and objectives In breast cancer patients, involvement of internal mammary lymph
nodes (IMLN) may be observed [1, 2], and ithas been demonstrated to be a marker of …
nodes (IMLN) may be observed [1, 2], and ithas been demonstrated to be a marker of …